{
  "trial_id": "NCT02276872",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, weight, gender, PAH diagnosis duration, type of PAH (IPAH, HPAH, congenital heart disease), baseline PAH therapy (IV/SC Remodulin, inhaled prostacyclin, other PAH medications), pulmonary arterial pressure (PAPm), pulmonary vascular resistance index (PVRi), left ventricular end-diastolic pressure (LVEDP), pulmonary capillary wedge pressure (PCWP), oxygen saturation, ability to swallow tablets, compliance with dietary requirements, renal function (creatinine clearance), liver function (AST, ALT levels), hemoglobin/hematocrit levels, psychiatric condition, infection status, investigational drug/device use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "PAH diagnosis duration",
        "type of PAH (IPAH, HPAH, congenital heart disease)",
        "baseline PAH therapy (IV/SC Remodulin, inhaled prostacyclin, other PAH medications)",
        "pulmonary arterial pressure (PAPm)",
        "pulmonary vascular resistance index (PVRi)",
        "left ventricular end-diastolic pressure (LVEDP)",
        "pulmonary capillary wedge pressure (PCWP)",
        "oxygen saturation",
        "ability to swallow tablets",
        "compliance with dietary requirements",
        "renal function (creatinine clearance)",
        "liver function (AST, ALT levels)",
        "hemoglobin/hematocrit levels",
        "psychiatric condition",
        "infection status",
        "investigational drug/device use"
      ]
    },
    "processed-gen-response": "Age, weight, gender, PAH diagnosis duration, type of PAH (IPAH, HPAH, congenital heart disease), baseline PAH therapy (IV/SC Remodulin, inhaled prostacyclin, other PAH medications), pulmonary arterial pressure (PAPm), pulmonary vascular resistance index (PVRi), left ventricular end-diastolic pressure (LVEDP), pulmonary capillary wedge pressure (PCWP), oxygen saturation, ability to swallow tablets, compliance with dietary requirements, renal function (creatinine clearance), liver function (AST, ALT levels), hemoglobin/hematocrit levels, psychiatric condition, infection status, investigational drug/device use."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Weight, PAH Diagnosis Duration, Baseline PAH Medications, Pulmonary Arterial Pressure, Pulmonary Vascular Resistance Index, Left Ventricular End-Diastolic Pressure, Pulmonary Capillary Wedge Pressure, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin, Hematocrit, Liver Function Tests, Renal Function (Creatinine Clearance),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Weight",
        "PAH Diagnosis Duration",
        "Baseline PAH Medications",
        "Pulmonary Arterial Pressure",
        "Pulmonary Vascular Resistance Index",
        "Left Ventricular End-Diastolic Pressure",
        "Pulmonary Capillary Wedge Pressure",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Hemoglobin",
        "Hematocrit",
        "Liver Function Tests",
        "Renal Function (Creatinine Clearance)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Weight, PAH Diagnosis Duration, Baseline PAH Medications, Pulmonary Arterial Pressure, Pulmonary Vascular Resistance Index, Left Ventricular End-Diastolic Pressure, Pulmonary Capillary Wedge Pressure, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin, Hematocrit, Liver Function Tests, Renal Function (Creatinine Clearance)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Weight, Height, Body Mass Index, PAH diagnosis duration, WHO functional class, PAPm, PVRi, LVEDP or PCWP, Current PAH medications, Background PAH therapies.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Weight",
        "Height",
        "Body Mass Index",
        "PAH diagnosis duration",
        "WHO functional class",
        "PAPm",
        "PVRi",
        "LVEDP or PCWP",
        "Current PAH medications",
        "Background PAH therapies."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Weight, Height, Body Mass Index, PAH diagnosis duration, WHO functional class, PAPm, PVRi, LVEDP or PCWP, Current PAH medications, Background PAH therapies."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, weight, height, race, ethnicity, PAH diagnosis (IPAH or HPAH), PAH associated with congenital systemic-to-pulmonary cardiac shunt, congenital heart disease, or other congenital heart lesions, PAPm, PVRi, LVEDP or PCWP, WHO functional class, background PAH therapies, concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "PAH diagnosis (IPAH or HPAH)",
        "PAH associated with congenital systemic-to-pulmonary cardiac shunt",
        "congenital heart disease",
        "or other congenital heart lesions",
        "PAPm",
        "PVRi",
        "LVEDP or PCWP",
        "WHO functional class",
        "background PAH therapies",
        "concomitant medications."
      ]
    },
    "processed-gen-response": "age, sex, weight, height, race, ethnicity, PAH diagnosis (IPAH or HPAH), PAH associated with congenital systemic-to-pulmonary cardiac shunt, congenital heart disease, or other congenital heart lesions, PAPm, PVRi, LVEDP or PCWP, WHO functional class, background PAH therapies, concomitant medications."
  }
}